3Danielski M,Ikizler TA,McMonagle E.et al.Linkage of hypoalbuminemia,inflammation.and oxidative stress in patients receiving maintenance hemodialysis therapy[J].Am J Kidney Dis,2003,42:286-294.
4Takahashi T,Kubota M,Nakamura T,et al.Interleukin-6 gene expression in peripheral blood mononuclear cells from patients undergoing hemodialysis or continuous ambulatory peritoneal dialysis[J].Ran Fail,2000,22:345-354.
5Schouten WE,Grooteman MP,van Houte AJ,et al.Effects of dialyser and dialysate on the acute phase reaction in clinical bicarbonate dialysis[J].Nephrol Dial Transplant,2000.15:379-384.
6Zamauskaite A,Perez-Cruz I,Yaqoob MM,et al.Effect of renal dialysis therapy modality on T cell cytokine production[J].Nephrol Dial Transplant,1999,14:49-55.
8Owen WF,Lowrie EG.C-reactive protein as an outcome predictor for maintenance hemodialysis patients[J].Kidney Int,1998,54:627-636.
9Elhage R,Clamens S.Besnard S,et al.Involvement of interleukin-6 in atherosclerosis but not in the preventionof fatty streak formation by 17beta-estradiol in apolipoprotein E-deficient mice[J].Atherosclerosis,2001,156:315-320.
10Kaysen GA,Chertow GM,Adhikarla R.et al.Inflammation and dietary protein intake exert competing effects on serum albumin and creatinine in hemodialysis patients[J].Kidney Int,2001,60:333-340.
